According to a recent study in JAMA, neither the sacrospinous ligament fixation (SSLF) nor the uterosacral ligament vaginal vault suspension (ULS) procedure is superior to the other in the treatment of vaginal prolapse and stress urinary incontinence.
According to a recent study in JAMA, neither the sacrospinous ligament fixation (SSLF) nor the uterosacral ligament vaginal vault suspension (ULS) procedure is superior to the other in the treatment of vaginal prolapse and stress urinary incontinence.
Researchers at the Cleveland Clinic performed a multicenter, 2 x 2 factorial, randomized trial of 374 patients who underwent surgery to treat both apical vaginal prolapse and stress urinary incontinence between 2008 and 2013 at 9 US medical centers and followed up with them 2 years later. The women were randomized to either the SSLF arm (n = 186) or ULS arm (n = 188) for surgical intervention; they were also randomized into 2 arms for behavioral intervention: perioperative pelvic floor muscle training (BMPT) (n = 186) or usual care (n = 188).
At the 2-year follow-up, the surgical group was not significantly associated with success rates (ULS, 59.2% [93/157] vs SSLF, 60.5% [92/152]; unadjusted difference, −1.3%; 95% confidence interval [CI], −12.2% to 9.6%; adjusted odds ratio [aOR], 0.9; 95% CI, 0.6 to 1.5) or serious adverse event rates (ULS, 16.5% [31/188] vs SSLF, 16.7% [31/186]; unadjusted difference, −0.2%; 95% CI, −7.7% to 7.4%; aOR, 0.9; 95% CI, 0.5 to 1.6). Women in the BMPT group had no greater improvements in urinary scores at 6 months (adjusted treatment difference, −6.7; 95% CI, −19.7 to 6.2), anatomic success at 24 months, or prolapse scores at 24 months (adjusted treatment difference, −8.0; 95% CI, −22.1 to 6.1).
The investigators concluded that neither ULS nor SSLF was superior to the other in terms of anatomic, functional, or adverse event outcomes. Similarly, perioperative BPMT showed no improvement in urinary symptoms at 6 months or prolapse outcomes at 2 years.
To get weekly advice for today's Ob/Gyn, subscribe to the Contemporary Ob/Gyn Special Delivery.
Phase 2b safety data for Sildenafil Cream against FSAD reported
August 26th 2024In a recent study published in The Journal of Sexual Medicine, Sildenafil Cream, 3.6% was indicated as safe and well-tolerated for use against female sexual arousal disorder in healthy premenopausal women.
Read More
Study: Pelvic floor dilator reduces pelvic floor muscle injury during vaginal delivery
August 6th 2024A new pilot study published in the International Urogynecology Journal found that Materna Medical’s Prep Device, a pelvic floor dilator, reduced full levator ani muscle avulsion during vaginal delivery in first-time mothers.
Read More
Similar success rates for synthetic and nonsynthetic slings in SUI treatment
July 31st 2024A study found that both synthetic and nonsynthetic slings show similar success rates for treating stress urinary incontinence in women, with synthetic slings demonstrating improved operative outcomes and reduced complications.
Read More
First hysterectomy using miniaturized MIRA Surgical System performed
July 30th 2024Virtual Incision Corporation has announced the successful performance of the first benign hysterectomy using their miniaturized robotic-assisted surgery device, MIRA, in a clinical trial assessing its safety and efficacy.
Read More